Wockhardt Ltd — Regulatory Filings 2023

Jun 21, 2023

Ref. No.: WOCK/SEC/SE/2023-24/019

==> picture [182 x 50] intentionally omitted <==

20[th] June, 2023

BSE Limited Corporate Relations Department P J Towers, Dalal Street, Mumbai 400 001

Scrip Code: 532300

National Stock Exchange of India Limited Exchange Plaza Bandra-Kurla Complex, Bandra (E), Mumbai 400 051

NSE Symbol – WOCKPHARMA

Dear Sir/ Madam,

Sub: Clarification on increase in volume of shares

This is with reference to letter Ref. No.: NSE/CM/Surveillance/13178 received from National Stock Exchange dated 20[th] June 2023 about significant movement in price of shares of the Company across Exchanges, in the recent past.

In this regard, we have to inform you that the Company has been making prompt disclosures of all events or information that has a material bearing on the operation / performance of the Company which includes all price sensitive information as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

At this point of time, the Company does not have any specific information/ announcement which has a material bearing on the price or volume behavior of the scrip. Please note that the Company submits the requisite disclosures to the Stock Exchanges and shall continue to do so as part of its obligation under Regulation 30 of the SEBI Listing Regulations or other relevant applicable laws.

Kindly take the same on record.

Thanking you,

For Wockhardt Limited

Debashi Digitally signed by Debashis Dey Date: 2023.06.20 s Dey 18:25:21 +05'30' Debashis Dey Company Secretary

==> picture [112 x 49] intentionally omitted <==

==> picture [513 x 32] intentionally omitted <==